AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

CUSIP: 037326105

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
37,347,828
Total 13F shares
11,741,328
Share change
+2,148,463
Total reported value
$99,891,167
Price per share
$8.50
Number of holders
30
Value change
+$18,097,549
Number of buys
11
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 037326105?
CUSIP 037326105 identifies ANTX - AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX) as of Q2 2023

As of 30 Jun 2023, AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,741,328 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BVF INC/IL, CITADEL ADVISORS LLC, TCG Crossover Management, LLC, JANUS HENDERSON GROUP PLC, Octagon Capital Advisors LP, Avidity Partners Management LP, VANGUARD GROUP INC, Monashee Investment Management LLC, and CITIGROUP INC. This page lists 30 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.